On April 1, 2024, Roger Lazarus, the Chief Financial Officer of Chain Bridge I, notified the board of directors of the company of his resignation, effective immediately. Mr. Lazarus will serve as an advisor to the Company through the end of April 2024 to ensure a smooth transition. Andrew Kucharchuk, age 43, succeeded Mr. Lazarus as the Company's Chief Financial Officer, effective April 1, 2024.

Mr. Kucharchuk has served as the Chief Financial Officer of Theralink Technologies Inc. (Theralink) since May 2023. Previously, he also served as President and Chief Financial Officer of Theralink from February 2016 until June 2020, as Chief Executive Officer of Theralink from November 2019 until June 2020 and as Acting Chief Financial Officer of Theralink from June 2020 to September 2020. He has served on the Board of Directors of Theralink since June 2020.

Mr. Kucharchuk also served as Chief Executive Officer and Chief Financial Officer of OncBioMune Inc. (OBMP) prior to Theralink's acquisition of OBMP. Mr. Kucharchuk served as the Chairman and Chief Operating Officer Adhera Therapeutics Inc. from July 2020 until September 2022 and its Chief Operations Officer from October 2022 to Present. Mr. Kucharchuk is a graduate of Louisiana State University and Tulane University's Freeman School of Business, where he earned an MBA with a Finance Concentration.